Lista de obras - Santiago Perez-Lloret - Dominio Público Uruguay

A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis

scientific article published on 09 October 2019

A cross-sectional study on drug use in multiple system atrophy

artículo científico publicado en 2014

A double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly

artículo científico publicado en 2002

A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients ⬇️

artículo científico publicado el 15 de noviembre de 2011

A multi-step pathway connecting short sleep duration to daytime somnolence, reduced attention, and poor academic performance: an exploratory cross-sectional study in teenagers

artículo científico publicado en 2013

A multifactorial study on nutritional status, binge eating and physical activity as main factors directly influencing body weight in Parkinson's disease

artículo científico publicado en 2017

A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson’s disease

artículo científico publicado en 2011

Actigraphic evaluation of motor fluctuations in patients with Parkinson's disease

artículo científico publicado en 2010

Activity-rest rhythm abnormalities in Parkinson's disease patients are related to dopaminergic therapy

artículo científico publicado en 2010

Addenbrooke's Cognitive Examination validation in Parkinson's disease

artículo científico publicado en 2008

Adverse drug reactions to dopamine agonists: a comparative study in the French Pharmacovigilance Database

artículo científico publicado en 2010

Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease: an old drug revisited ⬇️

artículo científico publicado el 11 de febrero de 2013

Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations

artículo científico publicado en 2020

Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease

artículo científico publicado en 2015

Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease

artículo científico publicado en 2016

Autosomal dominant cerebellar ataxias: a systematic review of clinical features

artículo científico publicado en 2014

Brief review: diurnal rhythms, obesity and educational achievement in South american cultures.

artículo científico publicado en 2009

Cardiac autonomic activity predicts dominance in verbal over spatial reasoning tasks: Results from a preliminary study ⬇️

artículo científico publicado el 25 de noviembre de 2011

Cerebroventricular administration of interferon-gamma modifies locomotor activity in the golden hamster

artículo científico publicado en 2003

Comparison of Olfactory Identification Patterns among Parkinson's Disease Patients from Different Countries.

artículo científico publicado en 2015

Correction to: Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort

artículo científico publicado en 2020

Current Concepts in the Treatment of Multiple System Atrophy

artículo científico publicado en 2015

Decision-making in Parkinson's disease patients with and without pathological gambling

artículo científico publicado en 2009

Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease

artículo científico publicado en 2016

Design and development of a novel supportive care product for the treatment of sialorrhea in Parkinson's disease

artículo científico

Disruption of ultradian and circadian rhythms of blood pressure in nondipper hypertensive patients

artículo científico publicado en 2004

Do Parkinson’s disease patients disclose their adverse events spontaneously? ⬇️

artículo científico publicado el 29 de diciembre de 2011

Does clinical intolerance to a diagnostic acute levodopa challenge differentiate multiple system atrophy from PD?

artículo científico publicado en 2009

Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease

artículo científico publicado el 1 de noviembre de 2010

Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases

artículo científico publicado en 2019

Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France

artículo científico publicado en 2011

Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database

artículo científico publicado en 2012

Dyskinesias induced by subthalamotomy in Parkinson's disease are unresponsive to amantadine

artículo científico publicado en 2006

Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25-35 in the suprachiasmatic nuclei

artículo científico publicado en 2002

Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia

artículo científico publicado en 2018

Emerging analgesic drugs for Parkinson's disease ⬇️

artículo científico publicado el 25 de abril de 2012

Emerging drugs for autonomic dysfunction in Parkinson's disease ⬇️

artículo científico publicado el 1 de febrero de 2013

Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort

artículo científico publicado en 2020

Factors related to orthostatic hypotension in Parkinson's disease

artículo científico publicado en 2012

Falls in ambulatory non-demented patients with Parkinson's disease

artículo científico publicado en 2015

Gender differences in age-related increase of asleep blood pressure.

artículo científico publicado en 2009

Heart rate nonlinear dynamics during sudden hypoxia at 8230 m simulated altitude

artículo científico publicado en 2009

Infradian awake and asleep systolic and diastolic blood pressure rhythms in humans

artículo científico publicado en 2006

Investigational drugs for autonomic dysfunction in Parkinson's disease

artículo científico publicado en 2016

Irritability, psychomotor agitation and progressive insomnia induced by bilateral stimulation of the area surrounding the dorsal subthalamic nucleus (zona incerta) in Parkinson's disease patients

artículo científico publicado en 2009

L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey

artículo científico publicado en 2017

Management of constipation in Parkinson's disease

artículo científico publicado en 2014

Movement Disorders After Exposure to Antipsychotic Drugs in Patients With Depressive Disorders

artículo científico publicado en 2018

Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review.

artículo científico publicado en 2014

New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study.

artículo científico publicado en 2015

New treatments for levodopa-induced motor complications

artículo científico

Nocturnal hypertension defined by fixed cut-off limits is a better predictor of left ventricular hypertrophy than non-dipping

scientific article published on 15 June 2007

Non-ergot dopamine agonists and the risk of heart failure and other adverse cardiovascular reactions in Parkinson's disease

artículo científico publicado en 2015

Nonmotor symptoms groups in Parkinson's disease patients: results of a pilot, exploratory study

artículo científico publicado en 2011

Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease

artículo científico publicado en 2015

Oro‐buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort ⬇️

artículo científico publicado el 1 de abril de 2011

Parkinson disease: Serotonin reuptake inhibitors for depression in PD.

artículo científico publicado en 2012

Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic

scientific article published on 11 September 2020

Parkinson's disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients

artículo científico publicado en 2009

Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration

artículo científico publicado en 2016

Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease

artículo científico publicado en 2016

Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease ⬇️

artículo científico publicado el 1 de septiembre de 2010

Pramipexole for the treatment of early Parkinson’s disease ⬇️

artículo científico publicado el 1 de julio de 2011

Predictors of Cardiovascular Autonomic Neuropathy Onset and Progression in a Cohort of Type 1 Diabetic Patients.

artículo científico publicado en 2018

Pregabalin Beneficial Effects on Sleep Quality or Health-Related Quality of Life Are Poorly Correlated With Reduction on Pain Intensity After an 8-Week Treatment Course ⬇️

artículo científico publicado el 1 de enero de 2012

Pregabalin-induced parkinsonism: a case report

artículo científico publicado en 2009

Prevalence and Pharmacological Factors Associated With Impulse-Control Disorder Symptoms in Patients With Parkinson Disease ⬇️

artículo científico publicado el 1 de noviembre de 2012

Prevalence and factors related to orthostatic syndromes in recently diagnosed, drug-naïve patients with Parkinson disease

scientific article published on 17 December 2019

Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease

artículo científico publicado en 2014

Prospective randomized 1-year follow-up comparison of bilateral subthalamotomy versus bilateral subthalamic stimulation and the combination of both in Parkinson's disease patients: a pilot study.

artículo científico publicado en 2008

Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations

scientific article published on 24 June 2016

Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease

artículo científico publicado en 2017

Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients

artículo científico publicado en 2014

Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson's Disease Animal Models from a Molecular Signaling Perspective

artículo científico publicado en 2020

Rotigotine transdermal delivery for the treatment of Parkinson's disease

artículo científico publicado en 2009

Rotigotine transdermal patch for the treatment of Parkinson’s Disease ⬇️

artículo científico publicado el 9 de febrero de 2012

Safety of rasagiline for the treatment of Parkinson's disease ⬇️

artículo científico publicado el 1 de abril de 2011

Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms

artículo científico

Sleep disordered breathing and daytime sleepiness are associated with poor academic performance in teenagers. A study using the Pediatric Daytime Sleepiness Scale (PDSS).

artículo científico publicado en 2007

Sleep habits, alertness, cortisol levels, and cardiac autonomic activity in short-distance bus drivers: differences between morning and afternoon shifts

artículo científico publicado en 2011

State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson's disease

artículo científico publicado en 2020

Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort

artículo científico publicado en 2015

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

artículo científico publicado en 2011

The Parkinson's disease pain classification system (PDPCS): results from an international mechanism-based classification approach

artículo científico publicado en 2020

The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease

artículo científico publicado en 2016

Therapeutic strategies for Parkinson's disease: promising agents in early clinical development

artículo científico publicado en 2020

Trends in inpatient antiparkinson drug use in the USA, 2001-2012.

artículo científico publicado en 2015

Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant

artículo científico publicado en 2014

Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review

artículo científico publicado en 2019

Utilization Patterns of Amantadine in Parkinson's Disease Patients Enrolled in the French COPARK Study

scientific article published on 01 March 2020

Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease

artículo científico publicado en 2007

Validation of a new scale to assess olfactory dysfunction in patients with Parkinson's disease

artículo científico publicado en 2012

Validation of the sleep related items of the Non-motor Symptoms Questionnaire for Parkinson's disease (NMSQuest).

artículo científico publicado en 2008

Lista de obras de Santiago Perez-Lloret

A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis

A cross-sectional study on drug use in multiple system atrophy

A double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly

A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients ⬇️

A multi-step pathway connecting short sleep duration to daytime somnolence, reduced attention, and poor academic performance: an exploratory cross-sectional study in teenagers

A multifactorial study on nutritional status, binge eating and physical activity as main factors directly influencing body weight in Parkinson's disease

A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson’s disease

Actigraphic evaluation of motor fluctuations in patients with Parkinson's disease

Activity-rest rhythm abnormalities in Parkinson's disease patients are related to dopaminergic therapy

Addenbrooke's Cognitive Examination validation in Parkinson's disease

Adverse drug reactions to dopamine agonists: a comparative study in the French Pharmacovigilance Database

Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease: an old drug revisited ⬇️

Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations

Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease

Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease

Autosomal dominant cerebellar ataxias: a systematic review of clinical features

Brief review: diurnal rhythms, obesity and educational achievement in South american cultures.

Cardiac autonomic activity predicts dominance in verbal over spatial reasoning tasks: Results from a preliminary study ⬇️

Cerebroventricular administration of interferon-gamma modifies locomotor activity in the golden hamster

Comparison of Olfactory Identification Patterns among Parkinson's Disease Patients from Different Countries.

Correction to: Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort

Current Concepts in the Treatment of Multiple System Atrophy

Decision-making in Parkinson's disease patients with and without pathological gambling

Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease

Design and development of a novel supportive care product for the treatment of sialorrhea in Parkinson's disease

Disruption of ultradian and circadian rhythms of blood pressure in nondipper hypertensive patients

Do Parkinson’s disease patients disclose their adverse events spontaneously? ⬇️

Does clinical intolerance to a diagnostic acute levodopa challenge differentiate multiple system atrophy from PD?

Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease

Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases

Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France

Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database

Dyskinesias induced by subthalamotomy in Parkinson's disease are unresponsive to amantadine

Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25-35 in the suprachiasmatic nuclei

Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia

Emerging analgesic drugs for Parkinson's disease ⬇️

Emerging drugs for autonomic dysfunction in Parkinson's disease ⬇️

Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort

Factors related to orthostatic hypotension in Parkinson's disease

Falls in ambulatory non-demented patients with Parkinson's disease

Gender differences in age-related increase of asleep blood pressure.

Heart rate nonlinear dynamics during sudden hypoxia at 8230 m simulated altitude

Infradian awake and asleep systolic and diastolic blood pressure rhythms in humans

Investigational drugs for autonomic dysfunction in Parkinson's disease

Irritability, psychomotor agitation and progressive insomnia induced by bilateral stimulation of the area surrounding the dorsal subthalamic nucleus (zona incerta) in Parkinson's disease patients

L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey

Management of constipation in Parkinson's disease

Movement Disorders After Exposure to Antipsychotic Drugs in Patients With Depressive Disorders

Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review.

New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study.

New treatments for levodopa-induced motor complications

Nocturnal hypertension defined by fixed cut-off limits is a better predictor of left ventricular hypertrophy than non-dipping

Non-ergot dopamine agonists and the risk of heart failure and other adverse cardiovascular reactions in Parkinson's disease

Nonmotor symptoms groups in Parkinson's disease patients: results of a pilot, exploratory study

Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease

Oro‐buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort ⬇️

Parkinson disease: Serotonin reuptake inhibitors for depression in PD.

Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic

Parkinson's disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients

Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration

Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease

Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease ⬇️

Pramipexole for the treatment of early Parkinson’s disease ⬇️

Predictors of Cardiovascular Autonomic Neuropathy Onset and Progression in a Cohort of Type 1 Diabetic Patients.

Pregabalin Beneficial Effects on Sleep Quality or Health-Related Quality of Life Are Poorly Correlated With Reduction on Pain Intensity After an 8-Week Treatment Course ⬇️

Pregabalin-induced parkinsonism: a case report

Prevalence and Pharmacological Factors Associated With Impulse-Control Disorder Symptoms in Patients With Parkinson Disease ⬇️

Prevalence and factors related to orthostatic syndromes in recently diagnosed, drug-naïve patients with Parkinson disease

Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease

Prospective randomized 1-year follow-up comparison of bilateral subthalamotomy versus bilateral subthalamic stimulation and the combination of both in Parkinson's disease patients: a pilot study.

Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations

Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease

Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients

Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson's Disease Animal Models from a Molecular Signaling Perspective

Rotigotine transdermal delivery for the treatment of Parkinson's disease

Rotigotine transdermal patch for the treatment of Parkinson’s Disease ⬇️

Safety of rasagiline for the treatment of Parkinson's disease ⬇️

Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms

Sleep disordered breathing and daytime sleepiness are associated with poor academic performance in teenagers. A study using the Pediatric Daytime Sleepiness Scale (PDSS).